Barnett S Kramer
Overview
Explore the profile of Barnett S Kramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
7250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu P, Steingrimsson J, Cole E, Cormack J, Dunn B, Gatsonis C, et al.
J Natl Cancer Inst Monogr
. 2025 Feb;
2025(68):42-48.
PMID: 39989037
This paper explores the design considerations and hurdles encountered by the CHinA National CancEr Screening (CHANCES) Trial and the Tomosynthesis Mammographic Imaging Screening Trial (TMIST), both aimed at advancing cancer...
2.
Gram E, Copp T, Ransohoff D, Pluddemann A, Kramer B, Woloshin S, et al.
BMJ
. 2024 Dec;
387():e080460.
PMID: 39631937
No abstract available.
3.
Xia C, Basu P, Kramer B, Li H, Qu C, Yu X, et al.
Lancet Public Health
. 2023 Nov;
8(12):e996-e1005.
PMID: 38000379
Cancer screening has the potential to decrease mortality from several common cancer types. The first cancer screening programme in China was initiated in 1958 and the Cancer High Incidence Fields...
4.
Dunn B, Woloshin S, Xie H, Kramer B
J Natl Cancer Cent
. 2022 Dec;
2(4):235-242.
PMID: 36568283
"Screening" is a search for preclinical, asymptomatic disease, including cancer. Widespread cancer screening has led to large increases in early-stage cancers and pre-cancers. Ubiquitous public messages emphasize the potential benefits...
5.
6.
Kramer B, Dai M, Beckwith M, Hu P, Li N, Ren J, et al.
J Natl Cancer Cent
. 2022 Feb;
1(1):12-14.
PMID: 35165676
No abstract available.
7.
Ropers F, Barratt A, Wilt T, Nicholls S, Taylor-Phillips S, Kramer B, et al.
BMJ
. 2021 Sep;
374:n2049.
PMID: 34580059
No abstract available.
8.
Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers
de Moor J, Mollica M, Sampson A, Adjei B, Weaver S, Geiger A, et al.
JNCI Cancer Spectr
. 2021 Jul;
5(3).
PMID: 34222790
Background: Cancer centers have a responsibility to help patients manage the costs of their cancer treatment. This article describes the availability of financial navigation services within the National Cancer Institute...
9.
Norton W, McCaskill-Stevens W, Chambers D, Stella P, Brawley O, Kramer B
JNCI Cancer Spectr
. 2021 Apr;
5(2).
PMID: 33860151
Patients, practitioners, and policy makers are increasingly concerned about the delivery of ineffective or low-value clinical practices in cancer care settings. Research is needed on how to effectively deimplement these...
10.
Baker S, Kramer B
Biomark Insights
. 2020 Aug;
15:1177271920946715.
PMID: 32821082
We review simple methods for evaluating 4 types of biomarkers. First, we discuss the evaluation of surrogate endpoint biomarkers (to shorten a randomized trial) using 2 statistical and 3 biological...